{"id":"W2283622962","doi":"10.1016/j.jaad.2016.01.013","title":"Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study","year":2016,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":155,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Tofacitinib; Medicine; Janus kinase inhibitor; Plaque psoriasis; Open label; Term (time); Psoriasis; Dermatology; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006434754,0.0003683394,0.002329812,0.0001418748,0.0002857541,0.00001424038,0.0005438777,0.0001698532,0.000008999311],"category_scores_gemma":[0.0002730792,0.0001626217,0.0002172674,0.0001263784,0.001843389,0.0001872312,0.0001989163,0.0001708661,0.000001288027],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008370391,"about_ca_system_score_gemma":0.0001027015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006289658,"about_ca_topic_score_gemma":0.00004730932,"domain_scores_codex":[0.9962319,0.001549142,0.001411763,0.0003826786,0.00009027105,0.0003342146],"domain_scores_gemma":[0.9929777,0.00409424,0.002416555,0.000324877,0.0001257175,0.00006086805],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4954304,0.005887151,0.0186906,0.0000407697,0.0117861,0.0000738251,0.004096233,0.000001702512,0.1045209,0.00004268464,0.0002978899,0.3591317],"study_design_scores_gemma":[0.7634673,0.007871425,0.1270123,0.0004163881,0.005018559,0.001173798,0.0008904685,0.000003534767,0.09339092,0.0001243644,0.000326845,0.0003040358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9657136,0.02825713,0.0000580486,0.003413723,0.0004549249,0.001798869,0.0002933578,0.000008654501,0.000001727222],"genre_scores_gemma":[0.9776186,0.02194583,0.0001082292,0.0000866742,0.00009954749,0.00005913325,0.00001277734,0.00002074293,0.0000484682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3588277,"threshold_uncertainty_score":0.6792042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05819594020406633,"score_gpt":0.362165703951438,"score_spread":0.3039697637473717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}